Search Orphan Drug Designations and Approvals
-
Generic Name: | trehalose |
---|---|
Date Designated: | 11/18/2020 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Seelos Therapeutics, Inc. 300 Park Avenue, 12th Floor New York, New York 10022 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-